Yope Biotechnology

Yope Biotechnology is a specialized biotechnology company headquartered in Suzhou, China, focusing on the intersection of chemoproteomics and drug discovery. The company utilizes a proprietary platform that combines high-throughput mass spectrometry with extensive covalent ligand libraries to map the 'ligandable' proteome and identify novel binding sites on previously undruggable targets. Yope's primary business model includes providing advanced proteomics services to pharmaceutical partners while simultaneously advancing an internal pipeline of covalent small molecule inhibitors. Their research is predominantly directed toward oncology and metabolic diseases, aiming to develop next-generation precision therapies. By integrating chemical biology with deep proteomic profiling, Yope Biotechnology seeks to accelerate the transition from target identification to lead optimization.